Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is given as a once-weekly injection to treat obesity and support sustainable weight loss. The standard approach begins with a low dose and increases gradually over 16 to 20 weeks, allowing your body to adapt and minimizing side effects. PlexusDx delivers compounded semaglutide from licensed 503A pharmacies, with dosing customized to your genetic profile and metabolic needs.
Standard Semaglutide Dosing Schedule for Weight Loss
Semaglutide follows a predictable weekly injection pattern designed to reach therapeutic doses safely. You inject once per week on the same day, with doses beginning at 0.25 mg and advancing in 0.25 mg increments every four weeks. The typical 16-week ramp reaches 1.0 mg weekly; some protocols continue to 2.4 mg depending on your response and tolerance. This gradual titration allows your GLP-1 receptors to acclimate, reducing nausea and gastrointestinal adaptation.
Your specific dose schedule depends on multiple factors: starting weight, metabolic rate, kidney function, medications you take, and how your body responds to lower doses. Some patients reach their effective weight-loss dose at 0.5 mg weekly, while others benefit from climbing to 1.5 mg or 2.4 mg. PlexusDx reviews your progress at each tier and adjusts timing based on real-world outcomes, not a one-size-fits-all protocol.
How Semaglutide Dosing Affects Weekly Weight Loss Results
Weekly semaglutide injections work by slowing stomach emptying, reducing hunger hormones, and increasing satiety signals to your brain. Higher doses amplify these effects, but the dose–response curve is not linear—moving from 0.5 mg to 1.0 mg often delivers larger weight-loss gains than moving from 1.5 mg to 2.4 mg. Clinical trials show average 10- to 15-pound weight loss over 16 weeks at maintenance doses, with continued loss over months two through six as your metabolism resets.
The week-to-week experience matters too: your appetite suppression deepens during the first three to four weeks after a dose increase, then stabilizes before the next step. This rhythm helps you build sustainable eating habits and avoid the compensatory hunger that derails dieting. PlexusDx monitors your weekly feedback to confirm you're progressing without excessive side effects or plateaus.
Once-Weekly Semaglutide Injections: Why This Frequency Works
Semaglutide has a long half-life of approximately seven days, making once-weekly dosing possible and practical. This longer duration means the drug accumulates gradually in your bloodstream, achieving steady-state levels by week four to five. Once-weekly injection timing keeps your appetite suppression consistent throughout the week, avoiding the peaks and troughs of daily or twice-weekly dosing, which can trigger rebound hunger on off-days.
The seven-day interval also simplifies adherence: pick the same day each week—Monday, Friday, Sunday—and your routine becomes automatic. Many patients combine their injection with another weekly habit, like meal planning or checking their scale, creating a behavioral anchor that improves long-term compliance. PlexusDx emphasizes this simplicity because consistency over six to twelve months is what drives sustained weight loss, not perfection in any single week.
Personalizing Your Semaglutide Dose Schedule With Genetic Testing
Your genetic blueprint influences how you respond to semaglutide and whether you'll do better at a standard dose or benefit from a customized approach. Key genetic variants in the GLP1R gene (rs6923761), FTO gene (rs9939609), and MC4R gene (rs17782313) predict your baseline appetite sensitivity, metabolic rate, and likelihood of rapid weight loss. PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides, identifying which genetic predispositions shape your semaglutide response before you start treatment.
Patients with certain genetic profiles may hit their plateau at 0.75 mg weekly and experience no additional benefit climbing to 2.4 mg, while others require the full dose range to achieve meaningful loss. The genetic test costs $99 as an add-on after your first month, giving you and your PlexusDx provider data to optimize your dose schedule for maximum results and minimum side effects. This precision approach shortens the trial-and-error phase and increases your confidence that the chosen dose is right for your body, not just the average patient.
Adjusting Your Semaglutide Frequency and Dose if You Hit a Plateau
Weight-loss plateaus are normal and expected, especially after three to six months of semaglutide therapy. When your weight stabilizes for more than two to three weeks despite adherence, your options include pausing the dose increase to let your body adapt, stepping up one tier if you haven't reached your target dose, or combining semaglutide with complementary therapies like oral medications or lifestyle adjustments. Some PlexusDx patients transition to GLP-Squared (semaglutide plus tirzepatide) if a plateau persists after dose optimization, leveraging dual-receptor activation for breakthrough loss.
Your injection frequency remains once weekly regardless of these adjustments—the timing never changes, only the dose strength. PlexusDx guides you through plateau management without rushing to higher doses that increase side-effect risk; the goal is sustainable, long-term weight maintenance, not rapid cycling through doses. Regular check-ins every two to four weeks ensure you're on track and confident in your protocol.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What time of day should I take my weekly semaglutide injection?
You can inject semaglutide at any time of day that fits your routine—morning, afternoon, or evening. The key is choosing the same day and approximate time each week to maintain steady blood levels. Most patients pick a day associated with another routine (Sunday meal prep, Friday evening) to build consistency. PlexusDx recommends documenting your injection day in a calendar or phone reminder so you never miss a dose.
How long does it take to see weight loss results from semaglutide?
Most patients notice reduced appetite within three to seven days of their first injection, though measurable weight loss typically appears after two to four weeks. By week eight to twelve, average loss ranges from 7 to 15 pounds. Maximum weight loss is usually achieved between months five and twelve, with total reductions of 15 to 25 pounds common at maintenance doses. Your genetics, starting weight, and diet adherence all influence your personal timeline.
Can I skip a week of semaglutide or change my injection schedule?
Skipping doses disrupts the steady-state levels you've built, often triggering rebound hunger and plateaus. If you need to delay an injection by a few days, that's acceptable, but regular weekly injections are essential for consistent results. If you're experiencing side effects that make weekly dosing difficult, contact PlexusDx to discuss dose reduction or slower titration rather than skipping weeks. Consistency is more important than dose strength.
Is semaglutide injection safe to use every week long-term?
Semaglutide is approved for chronic weight management and has been studied safely for over two years of continuous weekly use. Clinical trials and real-world data show that ongoing weekly injections maintain weight loss and improve metabolic health markers without serious cumulative toxicity. Side effects typically diminish after the first two to three months as your body adjusts. PlexusDx monitors your kidney function, liver health, and overall safety markers at regular intervals to ensure long-term tolerability.
How does the Precision Peptide Genetic Test help optimize my semaglutide schedule?
The test identifies genetic variants in GLP1R, GIPR, FTO, and MC4R genes that predict your appetite baseline, metabolic efficiency, and semaglutide response pattern. This data allows PlexusDx to anticipate whether you'll benefit from slower titration, rapid dose escalation, or combination therapy, personalizing your injection schedule before trial and error wastes time. Patients with genetic predispositions to rapid weight loss may need fewer weeks between dose increases, while others may plateau at lower doses—the test reveals your unique pattern upfront.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Much Weight Can I Lose on Compounded Tirzepatide?
Tirzepatide Results at 6 Months: Are You on Track